Form 4 for CLYM Climb Bio, Inc.
Accepted 2025-01-03 00:00:00 ET · period of report 2025-01-01 · accession 0000950170-25-001176 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2025-01-03 | 2025-01-01 | CLYM | Thomas Stephen Basil | Dir | M - OptEx | — | +50.2K | 154.1K | +48% | — |
| D | 2025-01-03 | 2025-01-01 | CLYM | Thomas Stephen Basil | Dir | M - OptEx | $0.00 | -50.2K | 50.2K | -50% | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-01-01 | M | A | 50,188 | — | 154,095 | D | — | — | (F1) Each restricted stock unit ("RSU") converted into one share of the Issuer's Common Stock. |
| 2 | Derivative | Restricted Stock Units | 2025-01-01 | M | D | 50,188 | $0.00 | 50,187 | D | — · — to — | 50,188 Common Stock | (F2) Each RSU represents a contingent right to receive one share of the Issuer's Common Stock. (F3) The RSUs were granted on June 27, 2024 and will vest as to 50% of the shares on January 1, 2025, as to 25% of the shares on March 27, 2025 and as to the remaining 25% of the shares on June 27, 2025, subject to the Reporting Person's continued service. |